Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W S Dalton

Showing results (1-10 of 135) with videos related to

Pageof 14
Sort By:
Seminars in Hematology|December 31, 1997
Mechanisms of drug resistance in hematologic malignanciesW S Dalton
Seminars in Oncology|February 1, 1993
Drug resistance modulation in the laboratory and the clinicW S Dalton
Hematology/Oncology Clinics of North America|October 23, 1997
Alternative (non-P-glycoprotein) mechanisms of drug resistance in non-Hodgkin's lymphomaW S Dalton
Seminars in Oncology|August 1, 1990
Mechanisms of drug resistance in breast cancerW S Dalton
Current Opinion in Oncology|November 1, 1994
Is p-glycoprotein a potential target for reversing clinical drug resistance?W S Dalton
Current Opinion in Oncology|December 1, 1991
Clinical and laboratory approaches to drug resistanceW S Dalton
Leukemia|July 1, 1997
Detection of multidrug resistance gene expression in multiple myelomaW S Dalton
Seminars in Oncology|October 21, 1999
Drug resistance in multiple myeloma: approaches to circumventionW S Dalton, R Jove
Applied Optics|March 18, 2010
Absorption cell for the infrared spectroscopy of heated gasW S Dalton, H Sakai
British Journal of Haematology|February 1, 1988
Reversal of drug-resistance in multiple myeloma with verapamilB G Durie, W S Dalton
Pageof 14

Showing results (1-10 of 135) with videos related to

Sort By:
Pageof 14
Seminars in Hematology|December 31, 1997
Mechanisms of drug resistance in hematologic malignanciesW S Dalton
Seminars in Oncology|February 1, 1993
Drug resistance modulation in the laboratory and the clinicW S Dalton
Hematology/Oncology Clinics of North America|October 23, 1997
Alternative (non-P-glycoprotein) mechanisms of drug resistance in non-Hodgkin's lymphomaW S Dalton
Seminars in Oncology|August 1, 1990
Mechanisms of drug resistance in breast cancerW S Dalton
Current Opinion in Oncology|November 1, 1994
Is p-glycoprotein a potential target for reversing clinical drug resistance?W S Dalton
Current Opinion in Oncology|December 1, 1991
Clinical and laboratory approaches to drug resistanceW S Dalton
Leukemia|July 1, 1997
Detection of multidrug resistance gene expression in multiple myelomaW S Dalton
Seminars in Oncology|October 21, 1999
Drug resistance in multiple myeloma: approaches to circumventionW S Dalton, R Jove
Applied Optics|March 18, 2010
Absorption cell for the infrared spectroscopy of heated gasW S Dalton, H Sakai
British Journal of Haematology|February 1, 1988
Reversal of drug-resistance in multiple myeloma with verapamilB G Durie, W S Dalton
Pageof 14